Cancer Groundshot: Building a Robust Cancer Control Platform in Addition To Launching the Cancer Moonshot

Abstract

Cancer Groundshot is a philosophy that calls for prioritization of strategies in global cancer control. The underlying principle of Cancer Groundshot is that one must ensure access to interventions that are already proven to work before focusing on the development of new interventions. In this article, we discuss the philosophy of Cancer Groundshot as it pertains to priorities in cancer care and research in low- and middle-income countries and the utility of technology in addressing global cancer disparities; we also address disparities seen in high-income countries. The oncology community needs to realign our priorities and focus on improving access to high-value cancer control strategies, rather than allocating resources primarily to the development of technologies that provide only marginal gains at a high cost. There are several “low-hanging fruit” actions that will improve access to quality cancer care in low- and middle-income countries and in high-income countries. Worldwide, cancer morbidity and mortality can be averted by implementing highly effective, low-cost interventions that are already known to work, rather than investing in the development of resource-intensive interventions to which most patients will not have access (i.e., we can use Cancer Groundshot to first save more lives before we focus on the “moonshots”).

The Impact of Artificial Intelligence on Health Equity in Oncology: Scoping Review

“…Although pilot studies can provide an important starting point, if not followed by a robust evaluation to measure the clinical effectiveness of these technologies, which occurs in only a minority of cases [ 176 ], these applications will remain an ineffective means of addressing global health disparities in cancer care. Moreover, it has been noted that most cancer deaths occurring in LMICs are due to a lack of access to already present and cost-effective diagnostic and treatment strategies, as opposed to the latest cutting-edge technology [ 177 , 178 ]. Exploratory research into novel technologies in global oncology may detract from the need to develop cost-effective ways to disseminate existing evidence-based technologies in cancer care.…”

Family and Caregiver Financial Toxicity Associated With Cancer—A Global, Inequitable, and Urgent Consideration

“…Although the Biden administration's Cancer Moonshot serves as a positive step in promoting cancer research and advocacy, a local and global "cancer groundshot" is needed to tackle the very real consequences of present cancer costs. 9 For example, investigation into the role of value-based pricing for cancer medications may identify ways to realign cost incentives in favor of patient needs. 10 Critically, however, policy-level solutions require complex study and multisectoral collaboration to tackle barriers to implementation, considering the often conflicting stakeholder interests.…”

“…The costs of cancer care continue to increase in ways that may not be sustainable in the long term for the US (and global) health care systems. Although the Biden administration’s Cancer Moonshot serves as a positive step in promoting cancer research and advocacy, a local and global “cancer groundshot” is needed to tackle the very real consequences of present cancer costs . For example, investigation into the role of value-based pricing for cancer medications may identify ways to realign cost incentives in favor of patient needs .…”

Financial toxicity of surgical treatment for gynecological cancer: A growing malignancy

“…The "Cancer Groundshot" initiative is a health equity strategy that prioritizes improving access to high quality cancer care above advancing new cancer treatments. It argues that effective delivery of known cures has the potential to decrease overall cancer morbidity and mortality far beyond the incremental gains provided by the next, million-dollar anti-cancer drug [11]. Building programs that work towards financial toxicity prevention and improve access is vital to improving quality care for the millions of patients with cancer currently struggling to receive optimal care.…”